Search Results - "Vilanova Boltó, M."

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    4CPS-156 Analysis of efectiveness and costs of drug therapy prescribed in special situations in our hospital by Parera Pascual, MM, De Amezaga Tomás, LPérez, Calderón Hernanz, B, Brady Garcia, A, Crespi Cifre, MA, Caballero Sanchez, M, Vilanova Boltó, M

    “…Background and ImportanceA marketing authorisation is a general rule in the legal framework of medicines. However, EU legislation does not regulate how drugs…”
    Get full text
    Journal Article
  2. 2

    4CPS-217 Clinical, economic and organisational impact of pharmacists’ interventions in oncological care patients by Parera Pascual, MM, González Morcillo, G, Bello Crespo, M, Nigorra Caro, M, Pérez de Amezaga Tomás, L, Brady Garcia, A, Crespí Cifre, MA, Vilanova Boltó, M

    “…Background and importanceClinical pharmacy is considered an integral discipline in the health care system to improve patients’ health outcomes by optimising…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    4CPS-077 Inhaled colistin as chronic suppressor therapy in patients with bronchiectasias with non-cystic fibrosis by Arrufat Goterris, G, Company Bezares, F, Oliver Noguera, A, Vilanova Bolto, M

    “…BackgroundPatients with non-cystic fibrosis (CF) bronchiectasis (BQ) are chronically colonised and infected by bacterial pathogens. The use of inhaled…”
    Get full text
    Journal Article
  6. 6

    Neurotoxicidad asociada a oxaliplatino en la práctica clínica asistencial by Mas Morey, P., Cholvi Llovell, M., Nigorra Caro, M., Nicolás Picó, J., Vilanova Boltó, M.

    Published in Farmacia hospitalaria (01-09-2012)
    “…Determinar la presencia de neurotoxicidad asociada a oxaliplatino en la práctica clínica asistencial, la gravedad de la misma y el manejo clínico relacionado…”
    Get full text
    Journal Article
  7. 7

    Comparaciones indirectas en los informes de evaluación de medicamentos en la web del grupo GENESIS de la SEFH by Ortega Eslava, A., Fraga Fuentes, M.D., Puigventós Latorre, F., Santos-Ramos, B., Clopés Estela, A., Vilanova Boltó, M.

    Published in Farmacia hospitalaria (01-07-2012)
    “…Cuantificar el uso de comparaciones indirectas (CI) en los informes de evaluación de medicamentos publicados en internet por el Grupo de Evaluación de…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Classification and variability of drug assessment reports on the GENESIS group (SEFH) webpage by Ortega Eslava, A, Puigventós Latorre, F, Santos-Ramos, B, Calderon Hernanz, B, Vilanova Boltó, M

    Published in Farmacia hospitalaria (01-05-2011)
    “…To analyse the assessment reports published on the GENESIS webpage (Group for Innovation, Assessment, Standardisation and Research in the Selection of Drugs)…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Caracterización y variabilidad de los informes de evaluación de medicamentos en la página web del grupo GENESIS de la SEFH by Ortega Eslava, A., Puigventós Latorre, F., Santos-Ramos, B., Calderon Hernanz, B., Vilanova Boltó, M.

    Published in Farmacia hospitalaria (01-05-2011)
    “…Analizar los informes de evaluación publicados en la página de Internet del Grupo de Evaluación de Novedades, Estandarización e Investigación en Selección de…”
    Get full text
    Journal Article
  14. 14

    Comparative study of errors in electronic versus manual prescription by Delgado Sánchez, O, Escrivá Torralva, A, Vilanova Boltó, M, Serrano López de las Hazas, J, Crespí Monjo, M, Pinteño Blanco, M, Martínez López, I, Tejada González, P, Cervera Peris, M, Fernández Cortés, F, Puigventós Latorre, F, Barroso Navarro, M A

    Published in Farmacia hospitalaria (01-07-2005)
    “…Electronic prescribing is considered a basic measure for the prevention and reduction of medications errors. The goal of this survey was to assess the…”
    Get full text
    Journal Article
  15. 15

    Oxaliplatin-associated neurotoxicity in clinical practice by Mas Morey, P, Cholvi Llovell, M, Nigorra Caro, M, Nicolás Picó, J, Vilanova Boltó, M

    “…To evaluate the presence and severity of oxaliplatin-associated neurotoxicity in clinical practice and the clinical management of this adverse side effect…”
    Get more information
    Journal Article
  16. 16

    Indirect comparisons in drug assessment reports on the GENESIS group (SEFH) webpage by Ortega Eslava, A, Fraga Fuentes, M D, Puigventós Latorre, F, Santos-Ramos, B, Clopés Estela, A, Vilanova Boltó, M

    “…Quantify use of indirect comparisons (IC) in drug evaluation reports published on the GENESIS Group web page for new drug assessment, standardisation, and drug…”
    Get more information
    Journal Article
  17. 17

    Compliance with hypertension treatment: 10 years of publications in Spain by Puigventós Latorre, F, Llodrà Ortolà, V, Vilanova Boltó, M, Delgado Sánchez, O, Lázaro Ferreruela, M, Forteza-Rey Borralleras, J, Serra Devecchi, J

    Published in Medicina clínica (22-11-1997)
    “…Ten years of publications (1984-1993) about drug compliance in spanish hypertensive patients are presented. A bibliography search of Medline (EBSCO CD-ROM ver…”
    Get more information
    Journal Article
  18. 18